CRISPR Therapeutics | 4:持股变动声明-高管 Kulkarni Samarth
04/17 17:50 (美东)
CRISPR Therapeutics | 144:拟议出售证券
04/15 16:29 (美东)
CRISPR Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Capital International Investors(10.2%)
04/10 12:02 (美东)
CRISPR Therapeutics | ARS:年度报告
04/09 16:51 (美东)
CRISPR Therapeutics | DEF 14A:股东委托书决议
04/09 16:47 (美东)
CRISPR Therapeutics | DEFA14A:其他
04/09 16:46 (美东)
CRISPR Therapeutics | PRE 14A:并购重组委托声明
03/27 16:36 (美东)
CRISPR Therapeutics | 4:持股变动声明-高管 KASINGER JAMES R.
03/22 17:48 (美东)
CRISPR Therapeutics | 4:持股变动声明-高管 Prasad Raju
03/22 17:48 (美东)
CRISPR Therapeutics | 4:持股变动声明-高管 Kulkarni Samarth
03/22 17:48 (美东)
CRISPR Therapeutics | 144:拟议出售证券
03/22 16:03 (美东)
CRISPR Therapeutics | 4:持股变动声明-高管 Kulkarni Samarth
03/18 17:46 (美东)
CRISPR Therapeutics | 4:持股变动声明-高管 Prasad Raju
03/18 17:46 (美东)
CRISPR Therapeutics | 144:拟议出售证券
03/15 16:51 (美东)
CRISPR Therapeutics | 4:持股变动声明-高管 KASINGER JAMES R.
03/12 17:49 (美东)
CRISPR Therapeutics | 4:持股变动声明-高管 Kulkarni Samarth
03/12 17:49 (美东)
CRISPR Therapeutics | 4:持股变动声明-董事 George Simeon
02/27 18:42 (美东)
CRISPR Therapeutics | 4:持股变动声明-高管 KASINGER JAMES R.
02/21 17:52 (美东)
CRISPR Therapeutics | 4:持股变动声明-高管 Kulkarni Samarth
02/21 17:52 (美东)
CRISPR Therapeutics | 10-K:年度报表
02/21 07:55 (美东)
暂无数据
暂无数据